Metro Minnesota Community Oncology Research Consortium — Saint Louis Park, Minnesota

Metro Minnesota Community Oncology Research Consortium is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Metro Minnesota Community Oncology Research Consortium has participated in 130 clinical trials with 34 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, Gynecologic Oncology Group, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Minnesota Community Oncology Research Consortium?

Metro Minnesota Community Oncology Research Consortium has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Minnesota Community Oncology Research Consortium conducted?

Metro Minnesota Community Oncology Research Consortium has 130 clinical trials on record, with 34 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Metro Minnesota Community Oncology Research Consortium accredited by Crixeo Health?

Metro Minnesota Community Oncology Research Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro Minnesota Community Oncology Research Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.